METFORMIN USE AND RISK OF COLORECTAL ADENOMA AFTER POLYPECTOMY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

BACKGROUND: Existing literature suggests that metformin, the most commonly used biguanide, may lower colorectal cancer (CRC) risk. Because most CRCs originate in pre-cancerous adenomas, we examined whether metformin use lowered colorectal adenoma risk after polypectomy in patients with type-2 diabet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Epidemiol Biomarkers Prev
Hauptverfasser: Marks, Amy R, Pietrofesa, Ralph A, Jensen, Christopher D, Zebrowski, Alexis, Corley, Douglas A, Doubeni, Chyke A
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633388/
https://ncbi.nlm.nih.gov/pubmed/26377195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-15-0559
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge